Kevin Michael Coveney Enveric Biosciences, Inc. (ENVB) insider trading activity

ENVB Quotes by TradingView

Kevin Michael Coveney is Chief Financial Officer of Enveric Biosciences, Inc.. Currently has a direct ownership of 47,413 shares of ENVB, which is worth approximately $250,340. The most recent transaction as insider was on Dec 23, 2025, when has been sold 40,198 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.4K
45.24% 3M change
74.58% 12M change
Total Value Held $250,340

Kevin Michael Coveney Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2025
BUY
Grant, award, or other acquisition
-
40,198 Added 45.88%
47,413 Common Stock
May 08 2025
BUY
Grant, award, or other acquisition
-
74,150 Added 46.13%
86,584 Common Stock
Oct 09 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 34.9%
186,500 Common Stock
Feb 22 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 40.96%
86,500 Common Stock
Mar 13 2023
BUY
Grant, award, or other acquisition
-
26,500 Added 50.0%
26,500 Common Stock
KMC

Kevin Michael Coveney

Chief Financial Officer
Naples, FL

Track Institutional and Insider Activities on ENVB

Follow Enveric Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENVB shares.

Notify only if

Insider Trading

Get notified when an Enveric Biosciences, Inc. insider buys or sells ENVB shares.

Notify only if

News

Receive news related to Enveric Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ENVB